Alzheimer’s disease is often associated with older adults, typically those over 65 years old. But for some, the journey begins much earlier — often in their 50s — when they are still in the prime ...

Recruiting and maintaining clinical trial participants continues to be a major obstacle to developing new therapies and treatments for those diagnosed with Alzheimer’s and Parkinson’s disease. Upwards ...

Community-based social groups could play a crucial role in empowering people with early-onset dementia, according to new UBC research. The study, led by UBC nursing professor Alison Phinney, focused ...

All-cause mortality risk was over six times higher for people with young-onset dementia versus controls. Median survival was 8.7 years, but varied by clinical type. People with young-onset ...